Tag
GRAIL
- bioAffinity Technologies reports more than 1,620 CyPath Lung tests
- GRAIL jumps 34% as FDA staff raise no major concerns on Galleri cancer test
- Lung cancer innovations showcased at ASCO 2026 as researchers pursue earlier detection
- China's Westlake University develops palm-sized lung cancer blood test
- Abbott's coronary imaging tech gets regulatory wins with FDA clearance, CE mark
- Tango Therapeutics rallies after oncology drug collaboration with Erasca
- Artificial intelligence boosts accuracy of pancreatic cancer diagnosis
- Boosting U.S. lung cancer screening uptake could save 62,000 lives in 5 years
- BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing
- University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research
- New blood test capable of screening for over 50 cancers available in Canada
- GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most